Integrated Approaches for the Use of Large Datasets to Identify Rational Therapies for the Treatment of Lung Cancers

Cancers
Robert J CardnellJing Wang

Abstract

The benefit and burden of contemporary techniques for the molecular characterization of samples is the vast amount of data generated. In the era of "big data", it has become imperative that we develop multi-disciplinary teams combining scientists, clinicians, and data analysts. In this review, we discuss a number of approaches developed by our University of Texas MD Anderson Lung Cancer Multidisciplinary Program to process and utilize such large datasets with the goal of identifying rational therapeutic options for biomarker-driven patient subsets. Large integrated datasets such as the The Cancer Genome Atlas (TCGA) for patient samples and the Cancer Cell Line Encyclopedia (CCLE) for tumor derived cell lines include genomic, transcriptomic, methylation, miRNA, and proteomic profiling alongside clinical data. To best use these datasets to address urgent questions such as whether we can define molecular subtypes of disease with specific therapeutic vulnerabilities, to quantify states such as epithelial-to-mesenchymal transition that are associated with resistance to treatment, or to identify potential therapeutic agents in models of cancer that are resistant to standard treatments required the development of tools for systematic,...Continue Reading

References

Oct 1, 1990·Antiviral Research·M N Prichard, C Shipman
Sep 24, 2005·Journal of Cell Science·Derek C Radisky
Jan 25, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ximing TangIgnacio I Wistuba
Mar 25, 2011·Drugs of Today·A TabchyG B Mills
May 16, 2012·Cancer Discovery·Edward S KimWaun K Hong
Oct 24, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Lauren Averett ByersJohn V Heymach
Oct 1, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Robert J CardnellLauren A Byers
Jul 15, 2015·Nature·Julie GeorgeRoman K Thomas
Oct 1, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Milena P MakLauren Averett Byers
Feb 26, 2016·Virchows Archiv : an International Journal of Pathology·Marius IliePaul Hofman
Jun 2, 2016·Journal of the National Cancer Institute·Eric PolleyBeverly A Teicher
Aug 3, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vassiliki PapadimitrakopoulouRoy S Herbst
Aug 3, 2017·Cancer Medicine·Beverly A TeicherDavid Evans
Jun 16, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M Catherine PietanzaLauren Averett Byers
Sep 28, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Carl M GayLauren A Byers

❮ Previous
Next ❯

Methods Mentioned

BETA
RNASeq
protein array
xenograft
Proteomic
biopsies
transcriptomic profiling

Software Mentioned

DISARM ( Differential Sensitivity Analysis for Resistant Malig...
DTECT
DISARM

Related Concepts

Related Feeds

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.